Orion Corporation

This article is about the pharmaceutical company. For other companies named Orion, see Orion (disambiguation).

Orion Oyj

Type	Julkinen osakeyhtiö
Traded as	Nasdaq Helsinki: ORNBV
Industry	Pharmaceutical industry
Founded	1917
Headquarters	Espoo, Finland
Key people	Timo Lappalainen (President and CEO), Hannu Syrjänen (Chairman)
Products	Pharmaceuticals, active pharmaceutical ingredients and diagnostic tests
Revenue	€1006.9 million (2013)^[1]
Operating income	€267.7 million (2013)^[1]
Profit	€206.2 million (2013)^[1]
Total assets	€979.0 million (2013)^[1]
Total equity	€513.9 million (2013)^[1]
Number of employees	3,519 (2013)^[1]
Website	www.orion.fi

Orion Corporation, founded in 1917 and headquartered at Espoo, Finland, is a Finnish company, which develops, manufactures and markets pharmaceuticals, active pharmaceutical ingredients and diagnostic tests for global markets. The company also has a large R&D unit in Turku.

Orion's class A and B shares are listed on the Helsinki Stock Exchange.

Products

This list is incomplete; you can help by expanding it.

Analgesics

Indalgin (indometacin, ethylmorphine)
Dexdor (dexmedetomidine)
Para-Tabs (paracetamol)
Lyrica (pregabalin)

NSAIDs

Burana (ibuprofen)
Ketorin (ketoprofen)
Pronaxen (naproxen)

Anti-diabetic drugs

Glimepirid Orion (glimepiride)
Metforem (metformin)
Origlucon (glibenclamide)

Gastric acid related drugs

Ranimex (ranitidine)
Zolt (lansoprazole)

Oral hygiene

Daktarin (miconazole)
Elmex (olaflur)

Motion sickness drugs

Vertipam (cyclizine, diazepam and nicotinic acid)

Vitamins

Cohemin (cyanocobalamin)
Neuramin (thiamine)

Anticoagulants

Marevan (warfarin)

Cardiovascular drugs

Digoxin (digoxin)
Disomet (disopyramide)
Dopmin (dopamine)
Kiniduron (quinidine)
Lidocard (lidocaine)
Nitro (glyceryl trinitrate)
Nitrosid (isosorbide dinitrate)
Ormox (isosorbide mononitrate)

Antihypertensive drugs

Amlodipin Orion (amlodipine)
Carvedilol Orion Pharma (carvedilol)
Dilzem (diltiazem)
Escor (nilvadipine)
Espesil (acebutolol)
Lisipril (lisinopril)
Lopril (captopril)
Nifangin (nifedipine)
Orloc (bisoprolol)
Pinloc (pindolol)
Pratsiol (prazosin)
Propral (propranolol)
Selopral (metoprolol)
Verpamil (verapamil)
Lisipril Comp (lisinopril and hydrochlorothiazide)
Orloc Comp (bisoprolol and hydrochlorothiazide)

Inotropic drugs

Simdax (levosimendan)

Diuretics

Diurex (hydrochlorothiazide and amiloride)
Furesis (furosemide)
Furesis Comp (furosemide and triamterene)
Hydrex (hydrochlorothiazide)
Indapamide Orion (indapamide)
Spiresis (spironolactone)
Uretren Comp (trichlormethiazide and triamterene)

Hypolipidemic agents

Atorvastatin Orion (atorvastatin)
Lovacol (lovastatin)
Pravastatin Orion (pravastatin)
Simvastatin Orion (simvastatin)

References

1 2 3 4 5 6 http://orion.fi/en/Orion-group/media/stock-exchange-releases/2014/orion-group-financial-statement-release-for-2013/

External links

Official website

OMX Helsinki 25 companies of Finland

Cargotec Elisa Fortum Kemira Kesko KONE Konecranes Metso Neste Nokia Nokian Tyres Nordea Orion Corporation Outokumpu Outotec Pohjola Bank Rautaruukki Sampo Sanoma Stora Enso Talvivaara Mining Company TeliaSonera UPM Wärtsilä YIT

This article is issued from Wikipedia - version of the 10/21/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.